The collaboration is pioneering a fresh wave of scientific inquiry into biological systems related to dermatology and hair care. The primary aims include developing breakthrough molecules and delivery platforms tailored for skin and scalp health, and exploring biotech-driven cosmetic solutions that go beyond traditional topical treatments.  

This strategic alliance leverages the respective strengths of each firm: OliX, known for its expertise in nextgeneration RNA-based therapeutics and targeted nanomedicines, and L’Oréal, with its long-standing knowledge in cosmetic science, formulation, and mass market distribution.   

Together, they are aiming to transform both the therapeutic and cosmetic dimensions of skin and hair care, utilising advanced molecular technologies to create highly effective, science-backed products.  

“We are very excited and look forward to working with L’Oréal, a leader in the global beauty industry, toward a common goal,” said Lee Dongki, CEO of OliX. “By integrating our robust platform technology with L’Oréal’s centurylong expertise in product development and their unwavering commitment to advancing the beauty sector, we aim to maximise the potential of both companies and achieve outstanding collaborative research outcomes.”